Found: 16
Select item for more details and to access through your institution.
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland.
- Published in:
- Hereditary Cancer in Clinical Practice, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s13053-022-00220-6
- By:
- Publication type:
- Article
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.
- Published in:
- Hereditary Cancer in Clinical Practice, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s13053-022-00218-0
- By:
- Publication type:
- Article
Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.
- Published in:
- Hereditary Cancer in Clinical Practice, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s13053-021-00208-8
- By:
- Publication type:
- Article
Smoking Related Cancers and Loci at Chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish Population.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025057
- By:
- Publication type:
- Article
Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study.
- Published in:
- Cancer Causes & Control, 2012, v. 23, n. 7, p. 1065, doi. 10.1007/s10552-012-9975-0
- By:
- Publication type:
- Article
Pilot Study: FSHR Expression in Neuroendocrine Tumors of the Appendix.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 15, p. 5086, doi. 10.3390/jcm12155086
- By:
- Publication type:
- Article
Preoperative Serum Levels of PDGF-AB, PDGF-BB, TGF-α, EGF and ANG-2 in the Diagnosis of Endometrial Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4815, doi. 10.3390/cancers15194815
- By:
- Publication type:
- Article
Recurrent Mutations in BRCA1 , BRCA2 , RAD51C , PALB2 and CHEK2 in Polish Patients with Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 849, doi. 10.3390/cancers13040849
- By:
- Publication type:
- Article
Survival of bladder or renal cancer in patients with CHEK2 mutations.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257132
- By:
- Publication type:
- Article
The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 126, n. 2, p. 521, doi. 10.1007/s10549-010-1123-5
- By:
- Publication type:
- Article
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 119, n. 1, p. 201, doi. 10.1007/s10549-009-0390-5
- By:
- Publication type:
- Article
Premature Menopause in Patients with BRCA1 Gene Mutation.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 100, n. 1, p. 59, doi. 10.1007/s10549-006-9220-1
- By:
- Publication type:
- Article
CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
- Published in:
- Familial Cancer, 2010, v. 9, n. 4, p. 605, doi. 10.1007/s10689-010-9381-2
- By:
- Publication type:
- Article
Blood and Serum Se and Zn Levels and 10-Year Survival of Patients after a Diagnosis of Kidney Cancer.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1775, doi. 10.3390/biomedicines12081775
- By:
- Publication type:
- Article
Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1574, doi. 10.3390/biomedicines11061574
- By:
- Publication type:
- Article
Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.
- Published in:
- Journal of Ovarian Research, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1757-2215-7-62
- By:
- Publication type:
- Article